Two Sigma Advisers
MURA

Two Sigma Advisers’s Mural Oncology MURA Stock Holding History

Two Sigma Advisers’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,200
Closed -$21.1K – 2529
2025
Q3 		$21.1K Buy
+10,200
New +$21.9K ﹤0.01% 2297
2025
Q2 		– Sell
-68,200
Closed -$85.9K – 2454
2025
Q1 		$85.9K Buy
68,200
+42,200
+162% +$154K ﹤0.01% 2258
2024
Q4 		$83.7K Buy
+26,000
New +$91.7K ﹤0.01% 2239

Two Sigma Advisers's MURA Position: Q4 2025 in Review

Two Sigma Advisers sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 10,200 shares — an estimated $21.1K sold.

Two Sigma Advisers first reported a position in MURA in Q4 2024 and held it in 3 quarters. The position peaked at $85.9K in Q1 2025. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

  • Two Sigma Advisers reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 10,200 Mural Oncology shares in Q4 2025, an estimated $21.1K.
  • Two Sigma Advisers first reported a position in Mural Oncology in Q4 2024 and held it in 3 quarters.
  • Two Sigma Advisers's Mural Oncology position peaked at $85.9K in Q1 2025.
  • 0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Two Sigma Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.